Aspen Pharmacare Pre-Tax Income 2017-2024 | APNHY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Aspen Pharmacare pre-tax income from 2017 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.

Aspen Pharmacare Pre-Tax Income 2017-2024 | APNHY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Aspen Pharmacare pre-tax income from 2017 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.

Related Stocks
Company Name	Market Cap
Teva Pharmaceutical Industries (TEVA)	$19B
Dr Reddy's Laboratories (RDY)	$12.3B
BridgeBio Pharma (BBIO)	$8.8B
Bausch Health Cos (BHC)	$2.5B
Supernus Pharmaceuticals (SUPN)	$1.9B
Amphastar Pharmaceuticals (AMPH)	$1B
Taysha Gene Therapies (TSHA)	$562M
Personalis (PSNL)	$493M
Assembly Biosciences (ASMB)	$140M
Sol-Gel Technologies (SLGL)	$33M
Evoke Pharma (EVOK)	$6M
Teligent (TLGT)	$0M